Equities
Find More Stocks
Find More Stocks
Use our equities screener to discover other potential opportunities.
 
Equities ScreenerGo to the Equities Screener

Forecasts data is unavailable for this security.

Share price forecast in EUR

The one analyst offering a 12 month price target expects Carl Zeiss Meditec AG share price to rise to 138.53 in the next year from the last price of 64.71.
High114.1%138.53
Med114.1%138.53
Low114.1%138.53

Dividends in EUR

Historical dividend information is not available for Carl Zeiss Meditec AG.
Div growth (TTM)0.00%
More ▼

Earnings history & estimates in EUR

On Aug 06, 2024, Carl Zeiss Meditec AG reported 3rd quarter 2024 earnings of 0.38 per share.
The next earnings announcement is expected on Dec 11, 2024.
Average growth rate-16.54%
Carl Zeiss Meditec AG reported annual 2023 earnings of 3.25 per share on Dec 12, 2023.
Average growth rate+23.16%
More ▼

Revenue history & estimates in EUR

-32768 had 3rd quarter 2024 revenues of 539.30m. This bettered the 509.37m consensus of the 3 analysts covering the company. This was 14.67% above the prior year's 3rd quarter results.
Average growth rate+0.97%
-32768 had revenues for the full year 2023 of 2.09bn. This was 9.80% above the prior year's results.
Average growth rate+10.04%
More ▼
Data Provided by LSEG
All markets data located on FT.com is subject to the FT Terms & Conditions
All content on FT.com is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by FT and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via FT.com is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. FT is not responsible for any use of content by you outside its scope as stated in the FT Terms & Conditions.